EGFR and neoplasm: In the pre-EGFR-TKI-treated tumor samples, pIGF-1R expression was evaluated using IHC staining and scored as very high (3+), high (2+), low (1+), and no (0) expression of pIGF-1R (Supplementary Fig. 4a).